Author:
Coppes Max J.,Jackson Cindy,Connor Edward M.
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference14 articles.
1. Allen, H. C. et al. Off-label medication use in children, more common than we think: a systematic review of the literature. J. Okla. State Med. Assoc. 111, 776–783 (2018).
2. Sachs, A. N., Avant, D., Lee, C. S., Rodriguez, W. & Murphy, M. D. Pediatric information in drug product labeling. JAMA 307, 1914–1915 (2012).
3. de Lima Costa, H. T. M., Costa, T. X., Martins, R. R. & Oliveira, A. G. Use of off-label and unlicensed medicines in neonatal intensive care. PLoS ONE 13, e0204427 (2018).
4. RACE Act poised to advance pediatric cancer research. Cancer Discov. 10: 1434 (2020).
5. Hwang, T. J., Bourgeois, F. T., Franklin, J. M. & Kesselheim, A. S. Impact of the priority review voucher program on drug development for rare pediatric diseases. Health Aff. 38, 313–319 (2019).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献